Why the Assumed Effect Matters
A beta-spending futility boundary is calibrated under an assumed treatment effect. That effect determines how likely the trial is to enter the lower, futility region at each analysis. If the assumed effect changes, a boundary designed to spend a specified amount of beta may no longer have the intended crossing probability. The direction is intuitive: under a larger beneficial effect, the test statistic tends to be higher, so a higher lower boundary is needed to retain the same lower-tail probability.
This sensitivity is important when the effect used for design is uncertain or when a proposed design is being adapted to a different target effect. A useful assessment separates two questions: what happens if the old boundaries are retained, and what new boundaries result if the same spending targets are recalibrated under a different effect? Those questions have different answers.
Model and Calibration Convention
Assume a normally distributed group sequential test statistic oriented so that larger values favour treatment. Let \(t_i=I_i/I_K\) be the information fraction at analysis \(i\), where \(I_i\) is the information at that analysis and \(I_K\) is the planned final information. Thus \(0<t_1<\cdots<t_K=1\). Write \(\theta\) for the assumed standardized drift at the final analysis. Under this design alternative, the canonical joint model is
In particular, \(Z_i\sim N(\theta\sqrt{t_i},1)\). The parameter \(\theta\) is measured in standard-deviation units of the final-analysis statistic; it is not an effect in the original outcome units. The corresponding treatment effect in original units must be translated through the test's standard error and information model.
For clarity, use a beta-spending convention in which \(B_i\) is the target cumulative probability of crossing a futility boundary by look \(i\), evaluated under the design alternative. The exact event must match the stopping rule: for a binding futility rule it includes the specified interaction with efficacy stopping, while for a nonbinding rule its calculation treats futility according to the chosen nonbinding convention. The convention must be held fixed when comparing effect assumptions. Cumulative spending targets satisfy \(B_1\leq\cdots\leq B_K\). A futility crossing probability is not automatically the overall type II error, which also involves final nonrejection and any competing stopping rules.
The canonical model assumes the planned information fractions are appropriate, the test statistics have the stated joint normal distribution, and the treatment effect is represented by a constant drift over the analyses. If these assumptions are unsuitable—for example, because information is materially misestimated or the effect changes over time—the calculated sensitivity may not describe the trial's actual behaviour.
One-Look Derivation of the Boundary Shift
At one analysis with information fraction \(t\), let the futility cutoff be \(l\), with futility declared when \(Z\leq l\). To spend a target amount \(B\) under the design alternative, require \(P_\theta(Z\leq l)=B\). Standardizing the normal variable gives
Here \(\Phi\) is the standard normal cumulative distribution function. Holding \(B\) and \(t\) fixed, the boundary's local and exact one-look change is
Thus a larger assumed beneficial effect shifts the cutoff upward in \(Z\)-units. The shift is smaller at an early look with little information and larger at a late look. This formula is exact for one marginal analysis; it is not, by itself, a multi-look boundary formula.
Worked Example: Recalibrating One Interim Cutoff
Suppose a hypothetical trial has one interim analysis at \(t=0.50\), and the target futility-crossing probability at that look is \(B=0.10\). First calibrate under \(\theta_1=2.00\), then under \(\theta_2=2.50\). There is no competing efficacy boundary in this one-look illustration.
The standard normal 10th percentile is \(\Phi^{-1}(0.10)=-1.2816\), and \(\sqrt{0.50}=0.7071\). Under \(\theta_1=2.00\), the mean of \(Z\) is \(2.00(0.7071)=1.4142\), so
Under \(\theta_2=2.50\), the mean is \(2.50(0.7071)=1.7678\), giving
The recalibrated cutoff rises by \(0.4862-0.1326=0.3536\), which also equals \((2.50-2.00)\sqrt{0.50}=0.3536\). Each cutoff gives a 10% marginal futility-crossing probability under its own assumed effect. These are \(Z\)-scale values, not treatment effects in the outcome's original units.
Holding a Boundary Fixed Changes Its Spending
If instead the original cutoff is retained after changing the assumed effect, its crossing probability generally changes. For a one-look boundary \(l\), the probability under a new effect \(\theta\) is
Its derivative with respect to \(\theta\) is \(-\sqrt{t}\,\phi(l-\theta\sqrt{t})\), which is negative because \(t>0\) and the standard normal density \(\phi\) is positive. A fixed lower cutoff therefore has a smaller crossing probability under a larger beneficial drift. This is a statement about futility crossing under the model, not a general statement that every measure of power changes by the same amount.
Worked Example: The Crossing Probability of an Old Cutoff
Continue with the hypothetical interim analysis at \(t=0.50\), but retain the cutoff calibrated under \(\theta=2.00\), namely \(l=0.1326\). Find its marginal futility-crossing probability if the assumed effect is instead \(\theta=2.50\).
At the new effect, \(E(Z)=2.50\sqrt{0.50}=1.7678\). Therefore,
The old cutoff now produces about a 5.1% marginal crossing probability, rather than the 10.0% target under which it was calibrated. The decrease is consistent with the higher mean of \(Z\). To restore the 10% target in this one-look example, the cutoff must be recalibrated to \(0.4862\), as in the preceding example.
Multi-Look Sensitivity Requires Joint Recalibration
With multiple analyses, the statistics are correlated. A path that has already crossed a lower boundary cannot be counted again as a new first crossing. Consequently, cumulative spending at look \(i\) depends on all earlier boundaries, not just on the marginal distribution \(Z_i\). In a simple nonbinding calculation without a competing efficacy stop, the calibration requirement can be written as
A binding rule or a convention that excludes paths stopped for efficacy requires the corresponding joint event instead. Either way, changing \(\theta\) changes the joint distribution's mean vector. The boundaries must be recalculated using the same crossing-event definition and the same spending targets; applying the one-look formula independently to each look need not satisfy the cumulative targets.
For fixed boundaries, increasing \(\theta\) shifts each component mean upward while leaving the canonical covariance matrix unchanged. The probability of crossing at least one fixed lower boundary by a given look therefore decreases. But when the boundaries are recalibrated sequentially, the earlier cutoffs also change. The resulting later cutoff is determined by a joint probability calculation, so the simple shift \((\theta_2-\theta_1)\sqrt{t_i}\) is not generally an exact multi-look adjustment.
Worked Example: Sensitivity at a Later Information Fraction
Consider a hypothetical single analysis at \(t=0.75\), with marginal target \(B=0.08\). Compare recalibrated cutoffs under \(\theta_1=1.60\) and \(\theta_2=2.00\). This is a one-look calculation, not a substitute for joint calibration in a multi-look design.
Since \(\Phi^{-1}(0.08)\approx-1.4051\) and \(\sqrt{0.75}=0.8660\), the means are \(1.60(0.8660)=1.3856\) and \(2.00(0.8660)=1.7321\). The cutoffs are
The difference is \(0.3465\), subject to rounding; the shift formula gives \((2.00-1.60)(0.8660)=0.3464\). Now suppose the cutoff calibrated at \(\theta=2.00\) is retained, but the actual drift is \(\theta=1.20\). The mean becomes \(1.20(0.8660)=1.0392\), so
The crossing probability is about 23.8%, substantially above the 8% design target. The calculation illustrates why evaluating a design only at its chosen alternative can conceal sensitivity to a weaker effect. It does not say that this crossing probability equals the trial's overall type II error.
How to Assess Sensitivity in Practice
A defensible sensitivity assessment keeps the design choices that are not under investigation fixed. In particular, hold the information fractions, cumulative spending targets, efficacy-boundary convention, and binding or nonbinding rule constant. Then vary the assumed effect over a scientifically plausible range and recalibrate the futility boundaries for each value. For each recalibration, verify the achieved cumulative futility-crossing probabilities under that same assumed effect.
Translate the clinically meaningful effect into the standardized drift \(\theta\) using the planned information model. Check that the direction of benefit agrees with the orientation of \(Z\).
Decide whether the question is about retaining existing boundaries or recalibrating them. State the spending targets and the exact futility-crossing event.
For each assumed effect, solve the joint boundary-calibration problem and check the achieved spending. Also report operating characteristics of interest under effects other than the calibration alternative.
The main alternative to recalibration is a fixed-boundary sensitivity analysis: keep the originally chosen cutoffs and calculate how crossing probabilities change across effect values. This answers what the existing design would do if its assumptions were wrong. Recalibration answers what boundaries would be required to meet the same spending targets under each alternative. Neither analysis replaces the other; they address different design questions.
Useful diagnostics include plotting each recalibrated cutoff against \(\theta\), checking that the calibration probabilities match their targets within numerical tolerance, and recomputing probabilities under several effects while holding the boundaries fixed. Unexpected direction or large discontinuities can signal a sign error, an inconsistent crossing-event definition, incorrect information fractions, or numerical integration problems. In multi-look calculations, verify the joint crossing probability rather than checking only the marginal tail probability at each analysis.
Sensitivity analysis has limits. It cannot protect against arbitrary departures from the assumed model, and it does not establish that any effect value is clinically plausible. A single drift parameter may also be inadequate when treatment effects vary over time or across populations. Finally, a boundary change alone does not summarize the design: report the corresponding crossing and overall operating characteristics, with their definitions, so readers can see what the design gains or loses.
Common Mistake
Wrong reasoning: “The assumed effect increased by 0.5, so I can add \(0.5\) to every futility boundary and preserve the beta spending.” This ignores the information scale: even for one look, the shift is multiplied by \(\sqrt{t}\). In a multi-look design, it also ignores correlation and the dependence of cumulative crossing probabilities on earlier boundaries.
Correction: Use the one-look shift formula only for a marginal one-look calibration. For a sequential design, keep the spending targets and stopping-rule definition fixed, then solve and verify the joint calibration again under the new effect.
Check Your Understanding
Answer each question, then compare with the concise solutions below.
- At \(t=0.36\), how much does a one-look cutoff change when \(\theta\) increases from 1.50 to 2.00, with the target crossing probability unchanged?
- A fixed lower cutoff is evaluated under a larger beneficial drift. Does its marginal futility-crossing probability increase or decrease? Give the reason.
- Why is it generally incorrect to apply the one-look cutoff formula separately at every analysis in a multi-look design?
- Under a design alternative, a calibrated futility-crossing probability is 0.10. Does that alone imply that the overall type II error is 0.10?
Solutions. (1) The change is \((2.00-1.50)\sqrt{0.36}=0.50(0.60)=0.300\) \(Z\)-units. (2) It decreases: \(P_\theta(Z\leq l)=\Phi(l-\theta\sqrt{t})\), whose argument decreases as \(\theta\) increases. (3) Sequential statistics are correlated, and cumulative crossing depends on earlier boundaries, so marginal quantiles do not generally deliver the specified joint spending. (4) No. Overall type II error also depends on final nonrejection and the specified stopping rule; crossing probability and overall beta are distinct operating characteristics.